Remsleep Holdings Inc. (RMSL) — SEC Filings
Remsleep Holdings Inc. (RMSL) — 11 SEC filings. Latest: 10-Q (Nov 19, 2025). Includes 6 10-Q, 2 10-K, 1 8-K.
View Remsleep Holdings Inc. on SEC EDGAR
Overview
Remsleep Holdings Inc. (RMSL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 19, 2025: RemSleep Holdings Inc. (RMSL) reported a significant decline in revenue and a substantial increase in net loss for the nine months ended September 30, 2025. Revenue plummeted by 90% to $12,278 from $122,735 in the prior year period. The net loss widened dramatically to $2,685,406, a 255% increase fr
Sentiment Summary
Across 11 filings, the sentiment breakdown is: 2 bearish, 9 neutral. The dominant filing sentiment for Remsleep Holdings Inc. is neutral.
Filing Type Overview
Remsleep Holdings Inc. (RMSL) has filed 6 10-Q, 2 10-K, 1 8-K, 1 10-Q/A, 1 S-1 with the SEC between Feb 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (11)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 19, 2025 | 10-Q | RemSleep's Revenue Plunges 90%, Net Loss Widens Amid Soaring Expenses | high |
| Aug 14, 2025 | 10-Q | RemSleep Revenue Plunges 94% Amidst Going Concern Doubts | high |
| May 13, 2025 | 10-Q | RemSleep Holdings Inc. Files Q1 2025 10-Q | low |
| Apr 14, 2025 | 10-K | RemSleep Holdings Inc. Files 2024 Annual Report | low |
| Nov 14, 2024 | 10-Q | RemSleep Holdings Inc. Files Q3 2024 10-Q Report | low |
| Aug 19, 2024 | 10-Q | RemSleep Holdings Inc. Files Q2 2024 10-Q Report | low |
| Jul 10, 2024 | 8-K | RemSleep Holdings Files 8-K Under 'Other Events' | low |
| May 29, 2024 | 10-Q/A | RemSleep Holdings Files 10-Q Amendment | low |
| May 17, 2024 | 10-Q | RemSleep Holdings Inc. Files Q1 2024 10-Q Report | medium |
| Apr 16, 2024 | 10-K | RemSleep Holdings Inc. Files Annual Report on Form 10-K | low |
| Feb 2, 2024 | S-1 | RemSleep Holdings Inc. Files S-1 Registration Statement | low |
Risk Profile
Risk Assessment: Of RMSL's 11 recent filings, 2 were flagged as high-risk, 1 as medium-risk, and 8 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $12,278 |
| Net Income | $(2,685,406) |
| EPS | N/A |
| Debt-to-Equity | 0.86 |
| Cash Position | $343,948 |
| Operating Margin | N/A |
| Total Assets | $464,065 |
| Total Debt | $214,725 |
Key Executives
- Thomas J. Wood
- Eric Newlan
Industry Context
RemSleep Holdings Inc. operates in the sleep apnea product market. This sector is characterized by a growing awareness of sleep disorders and demand for related medical devices and services. However, it also faces competition from established medical device manufacturers and requires significant investment in research, development, and regulatory compliance.
Top Tags
10-Q (5) · quarterly-report (4) · financials (3) · Sleep Apnea (2) · Medical Devices (2) · Going Concern (2) · Revenue Decline (2) · Net Loss (2) · Penny Stock (2) · 10-K (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $12,278 | 90% decrease from $122,735 in the prior year period |
| Net Loss | $(2,685,406) | 255% increase from $(756,088) in the prior year period |
| Related Party Compensation Expense | $2,248,000 | Significant increase from $105,000, driving losses |
| Cash | $343,948 | Decreased from $463,343 at year-end 2024 |
| Net Cash Used in Operating Activities | $(373,395) | Indicates ongoing cash burn from operations |
| Accumulated Deficit | $17,956,162 | Highlights severe historical losses and going concern risk |
| Common Shares Outstanding | 1,617,658,094 | As of November 18, 2025, indicating significant dilution |
| Revenue Decline | 90% | Year-over-year decline for the nine months ended September 30, 2025 |
| Net Loss Increase | 255% | Year-over-year increase for the nine months ended September 30, 2025 |
| Preferred Stock Issued for Services | $2,160,000 | Non-cash expense contributing to net loss |
| Interest Expense | $219,967 | Increased by 261.11% from $60,911 in prior year for six months ended June 30, 2025 |
| Loss on Issuance of Convertible Debt | $118,654 | New loss incurred for six months ended June 30, 2025 |
| Loss on Conversion of Debt | $54,133 | New loss incurred for six months ended June 30, 2025 |
| Change in Fair Value of Derivative | $283,361 | Positive change, significantly offsetting other expenses for six months ended June 30, 2025 |
| Total Operating Expenses | $268,091 | Decreased by 44.94% from $487,025 in prior year for six months ended June 30, 2025 |
Frequently Asked Questions
What are the latest SEC filings for Remsleep Holdings Inc. (RMSL)?
Remsleep Holdings Inc. has 11 recent SEC filings from Feb 2024 to Nov 2025, including 6 10-Q, 2 10-K, 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RMSL filings?
Across 11 filings, the sentiment breakdown is: 2 bearish, 9 neutral. The dominant sentiment is neutral.
Where can I find Remsleep Holdings Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Remsleep Holdings Inc. (RMSL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Remsleep Holdings Inc.?
Key financial highlights from Remsleep Holdings Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for RMSL?
The investment thesis for RMSL includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Remsleep Holdings Inc.?
Key executives identified across Remsleep Holdings Inc.'s filings include Thomas J. Wood, Eric Newlan.
What are the main risk factors for Remsleep Holdings Inc. stock?
Of RMSL's 11 assessed filings, 2 were flagged high-risk, 1 medium-risk, and 8 low-risk.
What are recent predictions and forward guidance from Remsleep Holdings Inc.?
Forward guidance and predictions for Remsleep Holdings Inc. are extracted from SEC filings as they are enriched.